Enfusion (ENFN) Competitors

CCC Intelligent Solutions (NYSE:CCCS) and Enfusion (NYSE:ENFN) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Do analysts prefer CCCS or ENFN?

CCC Intelligent Solutions presently has a consensus price target of $12.57, suggesting a potential upside of 35.76%. Enfusion has a consensus price target of $11.83, suggesting a potential upside of 9.07%. Given CCC Intelligent Solutions' stronger consensus rating and higher probable upside, analysts plainly believe CCC Intelligent Solutions is more favorable than Enfusion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CCC Intelligent Solutions	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
Enfusion	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has more volatility & risk, CCCS or ENFN?

CCC Intelligent Solutions has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Enfusion has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in CCCS or ENFN?

95.8% of CCC Intelligent Solutions shares are owned by institutional investors. Comparatively, 81.1% of Enfusion shares are owned by institutional investors. 6.0% of CCC Intelligent Solutions shares are owned by company insiders. Comparatively, 36.4% of Enfusion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community favor CCCS or ENFN?

CCC Intelligent Solutions received 18 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 45.90% of users gave CCC Intelligent Solutions an outperform vote while only 19.61% of users gave Enfusion an outperform vote.

Company	Underperform	Outperform
CCC Intelligent Solutions	Outperform Votes 28 45.90%	Underperform Votes 33 54.10%
Enfusion	Outperform Votes 10 19.61%	Underperform Votes 41 80.39%

Is CCCS or ENFN more profitable?

CCC Intelligent Solutions has a net margin of 5.02% compared to Enfusion's net margin of 1.70%. Enfusion's return on equity of 6.67% beat CCC Intelligent Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CCC Intelligent Solutions	5.02%	5.35%	3.23%
Enfusion	1.70%	6.67%	4.86%

Does the media refer more to CCCS or ENFN?

In the previous week, CCC Intelligent Solutions had 8 more articles in the media than Enfusion. MarketBeat recorded 11 mentions for CCC Intelligent Solutions and 3 mentions for Enfusion. CCC Intelligent Solutions' average media sentiment score of 1.57 beat Enfusion's score of 0.93 indicating that CCC Intelligent Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CCC Intelligent Solutions	10 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Enfusion	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings and valuation, CCCS or ENFN?

Enfusion has lower revenue, but higher earnings than CCC Intelligent Solutions. CCC Intelligent Solutions is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CCC Intelligent Solutions	$944.80M	6.46	-$92.48M	$0.04	231.50
Enfusion	$201.61M	6.94	$6.03M	$0.03	361.63

Summary

CCC Intelligent Solutions beats Enfusion on 12 of the 18 factors compared between the two stocks.